References

1. March WA, Moore VM, Willson KJ, Phillips DIW, Norman RJ, Davies MJ 2010 The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 25:544-551
2. Zawadski JK, Dunaif A 1992 Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Polycystic ovary syndrome. Current issues in endocrinology and metabolism. Boston: Blackwell Scientific Publications, 377-384
3. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF 2000 A Prospective Study of the Prevalence of the Polycystic Ovary Syndrome in Unselected Caucasian Women from Spain. J Clin Endocrinol Metab 85:2434-3515
4. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO 2004 The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89:2745-2749
5. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R 1998 Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study. J Clin Endocrinol Metab 83:3078-5091
6. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED, Bartzis MI 1999 A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 84:4006-4011
7. Alvarez-Blasco F, Botella-Carretero JI, San Millán JL, Escobar-Morreale HF 2006 Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women. Arch Intern Med 166:2081-2086
8. Davis SR, Knight S, White V, Claridge C, Davis BJ, Bell R 2002 Preliminary indication of a high prevalence of polycystic ovary syndrome in indigenous Australian women. Gynecol Endocrinol 16:443-446
9. Azziz R, Marin C, Hoq L, Badamgarav E, Song P 2005 Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. J Clin Endocrinol Metab 90:4650-4658
10.  Clark AM, Thornley B, Tomlinson L, Galletly C 1998 Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum Reprod 13:1502 - 1505
11.  Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, Witchel SF 2006 Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 91:4237-4245
12.  Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, Witchel SF 2009 The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 91:456-488
13.  ESHRE/ASRM 2004 Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome. Fertil Steril 81:19-25
14.  Moran L, Teede H 2009 Metabolic features of the reproductive phenotypes of polycystic ovary syndrome. Hum Reprod Update 15:477-488
15.  Michelmore K, Ong K, Mason S, Bennett S, Perry L, Vessey M, Balen A, Dunger D 2001 Clinical features in women with polycystic ovaries: relationships to insulin sensitivity, insulin gene VNTR and birth weight. Clin Endocrinol (Oxf) 55:439-446
16.  Vink JM, Sadrzadeh S, Lambalk CB, Boomsma DI 2006 Heritability of polycystic ovary syndrome in a Dutch twin-family study. J Clin Endocrinol Metab 91:2100-2104
17.  Kahsar-Miller MD, Nixon C, Boots LR, Go RC, Azziz R 2001 Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. Fertil Steril 75:53-58
18.  Acien P, Quereda F, Matallin P, Villarroya E, Lopez-Fernandez JA, Acien M, Mauri M, Alfayate R 1999 Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders. Fertil Steril 72:32-40
19.  Hutchison SK, Stepto NK, Harrison CL, Moran LJ, Strauss BJ, Teede HJ 2011 Effects of Exercise on Insulin Resistance and Body Composition in Overweight and Obese Women with and without Polycystic Ovary Syndrome. J Clin Endocrinol Metab 96:E48-56
20.  DeUgarte CM, Bartolucci AA, Azziz R 2005 Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril 83:1454-1460
21.  Dunaif A, Segal KR, Futterweit W, Dobrjansky A 1989 Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38:1165-1174
22.  Teede H 2008 CHECK Program: Polycystic ovary syndrome. The Royal Australian College of General Practitioners, Melbourne, 2008.
23.  Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R 2011 Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 7:219-231
24.  Evidence based guidelines for the assessment and management of polycystic ovary syndrome. Jean Hailes Foundation for Women’s Health on behalf of the PCOS Australian Alliance; Melbourne, 2011 www.managingpcos.org.au/pcos-evidence-based-guidelines
25.  Chittenden BG, Fullerton G, Maheshwari A, Bhattacharya S 2009 Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review. Reprod Biomed Online. 2009 Sep;19(3):398-405
26.  Boomsma CM, Eijkemans MJ, Hughes EG, Visser GH, Fauser BC, Macklon NS 2006 A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update 12:673-683
27.  Ferriman D, Gallwey J 1961 Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 21:1440-1447
28.  Meyer C, McGrath BP, Teede HJ 2005 Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease. J Clin Endocrinol Metab 90:5711-5716
29.  Diamanti-Kandarakis E, Papavassiliou AG 2006 Molecular mechanisms of insulin resistance in polycystic ovary syndrome. Trends Mol Med 12:324-332
30.  Dunaif A, Segal KR, Futterweit W, Dobrjansky A 1989 Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38:1165-1174
31.  Teede HJ, Hutchison SK, Zoungas S 2007 The management of insulin resistance in polycystic ovary syndrome. Trends Endocrinol Metab 18:273-279
32.  DeUgarte CM, Bartolucci AA, Azziz R 2005 Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril 83:1454-1460
33.  Dunaif A, Finegood DT 1996 Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab 81:942-947
34.  O'Meara N, Blackman JD, Ehrmann DA, Barnes RB, Jaspan JB, Rosenfield RL, Polonsky KS 1993 Defects in beta-cell function in functional ovarian hyperandrogenism. J Clin Endocrinol Metab 76:1241-1247
35.  Dunaif A 1997 Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18:774-800
36.  Corbould A, Kim Y-B, Youngren JF, Pender C, Kahn BB, Lee A, Dunaif A 2005 Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling. Am J Physiol Endocrinol Metab 288:E1047-1054
37.  Reaven GM 2008 Insulin resistance: the link between obesity and cardiovascular disease. Endocrinol Metab Clin North Am 37:581-601
38.  Legro RS, Kunselman AR, Dodson WC, Dunaif A 1999 Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome: A Prospective, Controlled Study in 254 Affected Women. J Clin Endocrinol Metab 84:165-168
39.  Moran LJ, Misso ML, Wild RA, Norman RJ 2010 Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 16:347-363
40.  Palmert MR, Gordon CM, Kartashov AI, Legro RS, Emans SJ, Dunaif A 2002 Screening for Abnormal Glucose Tolerance in Adolescents with Polycystic Ovary Syndrome. J Clin Endocrinol Metab 87:1017-1023
41.  Norman RJ, Masters L, Milner CR, Wang JX, Davies MJ 2001 Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome. Hum Reprod 16:1995-1998
42.  Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J 1999 Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22:141-146
43.  Boudreaux MY, Talbott EO, Kip KE, Brooks MM, Witchel SF 2006 Risk of T2DM and impaired fasting glucose among PCOS subjects: results of an 8-year follow-up. Curr Diab Rep 6:77-83
44.  Legro RS, Gnatuk CL, Kunselman AR, Dunaif A 2005 Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study. J Clin Endocrinol Metab 90:3236-3242
45.  Wild RA, Rizzo M, Clifton S, Carmina E 2011 Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril 95:1073-1079.e1011
46.  Meyer C, McGrath BP, Teede HJ 2007 Effects of Medical Therapy on Insulin Resistance and the Cardiovascular System in Polycystic Ovary Syndrome. Diabetes Care 30:471-478
47.  Wild RA, Carmina E, Diamanti-Kandarakis E, Dokras A, Escobar-Morreale HF, Futterweit W, Lobo R, Norman RJ, Talbott E, Dumesic DA 2010 Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab 95:2038-2049
48.  Shaw LJ, Bairey Merz CN, Azziz R, Stanczyk FZ, Sopko G, Braunstein GD, Kelsey SF, Kip KE, Cooper-Dehoff RM, Johnson BD, Vaccarino V, Reis SE, Bittner V, Hodgson TK, Rogers W, Pepine CJ 2008 Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. J Clin Endocrinol Metab 93:1276-1284
49.  de Groot PCM, Dekkers OM, Romijn JA, Dieben SWM, Helmerhorst FM 2011 PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis. Hum Reprod Update doi:10.1093/humupd/dmr001
50.  Salley KES, Wickham EP, Cheang KI, Essah PA, Karjane NW, Nestler JE 2007 POSITION STATEMENT: Glucose Intolerance in Polycystic Ovary Syndrome A Position Statement of the Androgen Excess Society. J Clin Endocrinol Metab 92:4546-4556

Content updated 7 September 2011